**Heart Failure**

- Avoid administration in patients with unstable heart failure or acute myocardial infarction.

**Hypertension**

- Intravenous (IV): 1.25 mg/dose given over 5 minutes every 6 hours. A clinical response typically occurs within 15 minutes.

- Concomitant diuretic therapy: start with 0.625 mg IV over 5 minutes.

- If the effect is inadequate after 1 hour: repeat the dose and administer 1.25 mg at 6-hour intervals
- If the effect is adequate after 1 hour: administer 0.625 mg IV every 6 hours

- Conversion from IV enalaprilat to enalapril:

- No concomitant diuretic therapy: initiate enalapril 5 mg once daily
- Concomitant diuretic therapy: initiate enalapril 2.5 mg once daily and titrate as needed

**Patients with Renal Impairment**

- Creatinine Clearance (CrCl) > 30 mL/minute: No dosage adjustment necessary

- CrCl ≤ 30 mL/minute: initiate 0.625 mg; if after 1 hour clinical response is unsatisfactory, repeat and then administer 1.25 mg every 6 hours

- Intermittent hemodialysis (IHD): 20 to 50% dialyzable (moderate)

- Initial: 0.625 mg IV over 5 to 60 minutes

- Conversion from IV enalaprilat to enalapril:

- CrCl > 30 mL/minute: initiate enalapril 5 mg once daily
- CrCl ≤ 30 mL/minute: initiate enalapril 2.5 mg once daily

Enalaprilat administration should be via IV push undiluted over at least 5 minutes or as an infusion diluted in up to 50 milliliters of D5W or 0.9% NaCl. Avoid salt substitutes or a potassium-rich diet. A dose no greater than 0.625 mg over 5 minutes should be administered in patients with heart failure or hyponatremia and patients undergoing intensive diuresis, an increase in diuretic dose, or renal dialysis.